|
MYGN
|
Myriad Genetics, Inc.
|
2.17%
|
US
|
NASDAQ
|
|
RCKT
|
Rocket Pharmaceuticals, Inc.
|
2.04%
|
US
|
NASDAQ
|
|
VRTX
|
Vertex Pharmaceuticals Incorporated
|
1.88%
|
US
|
NASDAQ
|
|
QURE
|
uniQure N.V.
|
1.63%
|
US
|
NASDAQ
|
|
RGNX
|
REGENXBIO Inc.
|
1.53%
|
US
|
NASDAQ
|
|
FLGT
|
Fulgent Genetics, Inc.
|
1.05%
|
US
|
NASDAQ
|
|
EDIT
|
Editas Medicine, Inc.
|
1.05%
|
US
|
NASDAQ
|
|
BLUE
|
bluebird bio, Inc.
|
1.01%
|
US
|
NASDAQ
|
|
CDNA
|
CareDx, Inc.
|
1.00%
|
US
|
NASDAQ
|
|
SRNE
|
Sorrento Therapeutics, Inc.
|
0.86%
|
US
|
NASDAQ
|
|
ALLO
|
Allogene Therapeutics, Inc.
|
0.82%
|
US
|
NASDAQ
|
|
NVTA
|
Invitae Corporation
|
0.78%
|
US
|
NYSE
|
|
SGMO
|
Sangamo BioSciences, Inc.
|
0.75%
|
US
|
NASDAQ
|
|
BNGO
|
Bionano Genomics, Inc.
|
0.71%
|
US
|
NASDAQ
|
|
NSTG
|
NanoString Technologies, Inc.
|
0.62%
|
US
|
NASDAQ
|
|
TSVT
|
2seventy bio, Inc.
|
0.60%
|
US
|
NASDAQ
|
|
CRBU
|
Caribou Biosciences, Inc.
|
0.60%
|
US
|
NASDAQ
|
|
STOK
|
Stoke Therapeutics, Inc.
|
0.32%
|
US
|
NASDAQ
|